World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
83
Citations
25191
World Ranking
989
National Ranking
451

Overview

Matthew B. Frieman is a researcher affiliated with the University of Maryland, Baltimore in the United States. Their work primarily focuses on the field of medicine, with significant contributions to subfields including infectious diseases, immunology, epidemiology, molecular biology, and animal science and zoology.

The main topics covered by Matthew B. Frieman's research include:

  • SARS-CoV-2 and COVID-19 research
  • COVID-19 clinical research studies
  • Animal virus infections studies
  • Interferon and immune responses
  • Respiratory viral infections research
  • Viral gastroenteritis research and epidemiology
  • SARS-CoV-2 detection and testing

Notable recent papers authored or co-authored by Frieman cover a range of topics related to COVID-19 and viral infections. Selected works include:

  • "Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail," 2020, Science
  • "Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine," 2020, New England Journal of Medicine
  • "Animal models for COVID-19," 2020, Nature
  • "Selective Naked-Eye Detection of SARS-CoV-2 Mediated by N Gene Targeted Antisense Oligonucleotide Capped Plasmonic Nanoparticles," 2020, ACS Nano
  • "SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice," 2021, Nature Communications

Frequent collaborators in Frieman's research include James Logue, Stuart Weston, Marisa E. McGrath, Carly Dillen, and Ralph S. Baric. These co-authors have multiple joint publications, indicating an active research network.

Regular publication venues for Frieman's work consist of:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • UNC Libraries
  • Nature Communications
  • Journal of Virology
  • Science Translational Medicine

Best Publications

  • Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail.

    Johanna Hansen;Alina Baum;Kristen E. Pascal;Vincenzo Russo

  • Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine.

    Cheryl Keech;Gary Albert;Iksung Cho;Andreana Robertson

  • Animal models for COVID-19.

    César Muñoz-Fontela;William E. Dowling;Simon G.P. Funnell;Pierre S. Gsell

  • Severe Acute Respiratory Syndrome Coronavirus Open Reading Frame (ORF) 3b, ORF 6, and Nucleocapsid Proteins Function as Interferon Antagonists

    Sarah A. Kopecky-Bromberg;Luis Martínez-Sobrido;Matthew Frieman;Ralph A. Baric

  • Selective Naked-Eye Detection of SARS-CoV-2 Mediated by N Gene Targeted Antisense Oligonucleotide Capped Plasmonic Nanoparticles.

    Parikshit Moitra;Maha Alafeef;Maha Alafeef;Maha Alafeef;Ketan Dighe;Matthew B. Frieman

  • Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.

    David E. Gordon;Joseph Hiatt;Mehdi Bouhaddou;Veronica V. Rezelj

  • Repurposing of Clinically Developed Drugs for Treatment of Middle East Respiratory Syndrome Coronavirus Infection

    Julie Dyall;Christopher M. Coleman;Brit J. Hart;Thiagarajan Venkataraman

  • Severe Acute Respiratory Syndrome Coronavirus ORF6 Antagonizes STAT1 Function by Sequestering Nuclear Import Factors on the Rough Endoplasmic Reticulum/Golgi Membrane

    Matthew Frieman;Boyd Yount;Mark Heise;Sarah A. Kopecky-Bromberg

  • Bats and Coronaviruses.

    Arinjay Banerjee;Kirsten Kulcsar;Vikram Misra;Matthew Frieman

  • SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice.

    Jing Hui Tian;Nita Patel;Robert Haupt;Haixia Zhou

  • Antiviral Potential of ERK/MAPK and PI3K/AKT/mTOR Signaling Modulation for Middle East Respiratory Syndrome Coronavirus Infection as Identified by Temporal Kinome Analysis

    Jason Kindrachuk;Britini Ork;Brit J. Hart;Steven Mazur

  • A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylactics.

    Longlong Si;Haiqing Bai;Melissa Rodas;Wuji Cao

  • Severe Acute Respiratory Syndrome Coronavirus Papain-Like Protease Ubiquitin-Like Domain and Catalytic Domain Regulate Antagonism of IRF3 and NF-κB Signaling

    Matthew Frieman;Kiira M. Ratia;Robert E. Johnston;Andrew D. Mesecar

  • Genetic analysis of complex traits in the emerging Collaborative Cross

    David L. Aylor;William Valdar;Wendy Foulds-Mathes;Ryan J. Buus

  • Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection

    Kirsten A. Kulcsar;Christopher M. Coleman;Sarah E. Beck;Matthew B. Frieman

  • Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain.

    Marc G. Wathelet;Melissa Orr;Matthew B. Frieman;Ralph S. Baric

  • Evidence Supporting a Zoonotic Origin of Human Coronavirus Strain NL63

    Jeremy Huynh;Shimena Li;Boyd Yount;Alexander Smith

  • Purified coronavirus Spike protein nanoparticles induce coronavirus neutralizing antibodies in mice

    Christopher M. Coleman;Ye V. Liu;Haiyan Mu;Justin K. Taylor

  • Severe acute respiratory syndrome coronavirus group-specific open reading frames encode nonessential functions for replication in cell cultures and mice

    Boyd Yount;Rhonda S. Roberts;Amy C. Sims;Damon Deming

  • Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2.

    Saman Saadat;Zahra Rikhtegaran Tehrani;James Logue;Michelle Newman

  • Insights from nanomedicine into chloroquine efficacy against COVID-19.

    Tony Y. Hu;Matthew Frieman;Joy Wolfram

Frequent Co-Authors

Ralph S. Baric
Ralph S. Baric University of North Carolina at Chapel Hill
Mark T. Heise
Mark T. Heise University of North Carolina at Chapel Hill
Boyd Yount
Boyd Yount University of North Carolina at Chapel Hill
Lisa E. Hensley
Lisa E. Hensley National Institutes of Health
Peter B. Jahrling
Peter B. Jahrling National Institute of Allergy and Infectious Diseases
Donald E. Ingber
Donald E. Ingber Harvard University
Gale Smith
Gale Smith Novavax (United States)
Eric F. Donaldson
Eric F. Donaldson Center for Drug Evaluation and Research
Michael R. Holbrook
Michael R. Holbrook National Institutes of Health
Adolfo García-Sastre
Adolfo García-Sastre Icahn School of Medicine at Mount Sinai

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in studying microbiology in the USA, exploring complementary online degrees can broaden career opportunities. Programs like an online health information management degree programs cahiim accredited provide essential skills for managing healthcare data, which is increasingly important in biological research and clinical settings.

Medical billing and coding is another relevant field, offering quick certification pathways. Many students benefit from fast online medical billing and coding certification programs, which can lead to entry-level positions in healthcare administration—roles that frequently collaborate with microbiology labs and healthcare providers.

Beyond microbiology, there are several online healthcare degrees that pay well, such as nursing and public health, which align well with a background in biological sciences. These degrees offer both flexibility and strong return on investment, especially when pursued online.

Public health professionals play a vital role in disease control and prevention. For those wanting to expand into this area, numerous accredited online mph programs easy to get into can provide a smooth entry point into the public health sector, complementing microbiology expertise and opening doors to diverse career pathways.

Best Scientists Citing Matthew B. Frieman

Trending Scientists